Almost one in ten young adults report current e-cigarette use, putting them at risk of developing nicotine addiction and long-term health effects of exposure to inhaled toxicants. Despite the need for effective treatments to help these young users quit, very few treatments targeting any type of tobacco use among young adults have been evaluated, particularly for young adults who vape and have unique treatment needs. To address these needs, this trial will evaluate a digital program for young adult e-cigarette users at all stages of readiness to quit called ACT on Vaping.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Overall Treatment Satisfaction Rating
Timeframe: At 3 months post-randomization
Change in Readiness to Quit
Timeframe: From baseline to 3 months post-randomization
Percentage of Participants With a 24-hour Quit Attempt
Timeframe: At 3 months post-randomization
Cotinine-confirmed 30-day Point Prevalence Abstinence From All Nicotine and Tobacco
Timeframe: At 3 months post-randomization